Literature DB >> 17705277

Pancreatic and duodenal homeobox gene 1 induces hepatic dedifferentiation by suppressing the expression of CCAAT/enhancer-binding protein beta.

Irit Meivar-Levy1, Tamar Sapir, Shiraz Gefen-Halevi, Vered Aviv, Iris Barshack, Nicholas Onaca, Eytan Mor, Sarah Ferber.   

Abstract

UNLABELLED: It is believed that adult tissues in mammals lack the plasticity needed to assume new developmental fates because of the absence of efficient pathways of dedifferentiation. However, the well-documented ability of the transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) to activate pancreatic lineage development and insulin production following ectopic expression in liver suggests a surprising degree of residual plasticity in adult liver cells. This study seeks a mechanistic explanation for the capacity of PDX-1 to endow liver cells with pancreatic characteristics and function. We demonstrate that PDX-1, previously shown to play an essential role in normal pancreatic organogenesis and pancreatic beta-cell function and to possess the potential to activate multiple pancreatic markers in liver, can also direct hepatic dedifferentiation. PDX-1 represses the adult hepatic repertoire of gene expression and activates the expression of the immature hepatic marker alpha-fetoprotein. We present evidence indicating that PDX-1 triggers hepatic dedifferentiation by repressing the key hepatic transcription factor CCAAT/enhancer-binding protein beta. Hepatic dedifferentiation is necessary though not sufficient for the activation of the mature pancreatic repertoire in liver.
CONCLUSION: Our study suggests a dual role for PDX-1 in liver: inducing hepatic dedifferentiation and activating the pancreatic lineage. The identification of dedifferentiation signals may promote the capacity to endow mature tissues in mammals with the plasticity needed for acquiring novel developmental fates and functions to be implemented in the field of regenerative medicine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705277     DOI: 10.1002/hep.21766

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

1.  Pancreatic and duodenal homeobox gene 1 (Pdx1) down-regulates hepatic transcription factor 1 alpha (HNF1α) expression during reprogramming of human hepatic cells into insulin-producing cells.

Authors:  William Donelan; Shiwu Li; Hai Wang; Shun Lu; Chao Xie; Dongqi Tang; Lung-Ji Chang; Li-Jun Yang
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

Review 2.  Defining the cancer master switch.

Authors:  Courtney J Balentine; David H Berger; Shi-He Liu; Changyi Chen; John Nemunaitis; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 3.  Minireview: beta-cell replacement therapy for diabetes in the 21st century: manipulation of cell fate by directed differentiation.

Authors:  Vijay Yechoor; Lawrence Chan
Journal:  Mol Endocrinol       Date:  2010-03-10

Review 4.  Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration.

Authors:  Chris Jopling; Stephanie Boue; Juan Carlos Izpisua Belmonte
Journal:  Nat Rev Mol Cell Biol       Date:  2011-02       Impact factor: 94.444

Review 5.  Present and future cell therapies for pancreatic beta cell replenishment.

Authors:  Juan Domínguez-Bendala; Camillo Ricordi
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

6.  V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting Cells.

Authors:  Elisa Corritore; Yong-Syu Lee; Valentina Pasquale; Daniela Liberati; Mei-Ju Hsu; Catherine Anne Lombard; Patrick Van Der Smissen; Amedeo Vetere; Susan Bonner-Weir; Lorenzo Piemonti; Etienne Sokal; Philippe A Lysy
Journal:  Stem Cells Transl Med       Date:  2016-07-12       Impact factor: 6.940

7.  Epigenetic modifications and canonical wingless/int-1 class (WNT) signaling enable trans-differentiation of nonosteogenic cells into osteoblasts.

Authors:  Young-Dan Cho; Won-Joon Yoon; Woo-Jin Kim; Kyung-Mi Woo; Jeong-Hwa Baek; Gene Lee; Young Ku; Andre J van Wijnen; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

Review 8.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 9.  Liver to Pancreas Transdifferentiation.

Authors:  Irit Meivar-Levy; Sarah Ferber
Journal:  Curr Diab Rep       Date:  2019-08-02       Impact factor: 4.810

Review 10.  Promoting ectopic pancreatic fates: pancreas development and future diabetes therapies.

Authors:  E J Pearl; M E Horb
Journal:  Clin Genet       Date:  2008-09-09       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.